Dentsply Sirona Q1 2026: Mixed Results, AI & Growth

Dentsply Sironas Q1 2026 earnings show a slight revenue increase of 0.1% to $880 million, but a 6.7% drop on constant currency. Adjusted EPS hit $0.27, with margins impacted by lower volumes and tariffs. Despite this, they maintain their full-year sales outlook of $3.5-3.6 billion and EPS of $1.40-1.50. The company is focused on their Return to Growth plan, reducing operating expenses by $20 million, boosting cash flow to $40 million, and paying down $79 million in debt. Segments varied, with declines in consumables and implants offset by strong growth in Asia Pacific equipment and steady gains in Wellspect healthcare. New launches include AI-powered SmartView Detect for root inflammation, cordless endodontic tools, and a dental MRI. Theyve also signed a fourth U.S. distributor deal with Atlanta Dental Supply, expanding their reach. Restructuring is on track for $120 million in annual savings, reinvested in growth. Despite challenges, Dentsply Sirona is optimistic about second-half momentum and 2027 upside, focusing on AI tools, supply chain improvements, and implant enhancements. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/cd25d8a5809a79da